Cite
HARVARD Citation
Bourlière, M. et al. (n.d.). Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). Lancet infectious diseases. 15 (4), pp. 397-404. [Online].